Learn about how we combine iPSC-derived models with CROP-Seq (CRISPR droplet sequencing) to enhance drug discovery. Using this approach, we combine pooled CRISPR screening with single-cell RNA sequencing and interrogate the transcriptomic phenotypes of large numbers of genetic perturbations at single cell resolution.

Our technology has applications in target identification and validation, mechanism of action studies and disease modelling.

Download our factsheet below to find out more.